On-treatment Adaptation of Head and Neck Cancer Dosimetry Plans Using Novel Cone-beam CT and AI-driven Software

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 10, 2023

Primary Completion Date

December 19, 2024

Study Completion Date

December 19, 2024

Conditions
Head and Neck Cancer
Interventions
DEVICE

CBCT Imaging

Subjects are scheduled for two imaging sessions on the Ethos system with the HyperSight CBCT. One session is on the same day as the CT simulation scan for treatment planning. The second session is on the same day as the delivery of ther 21st treatment fraction. If the subject is sent for a mid-treatment FBCT for re-planning, a third HyperSight CBCT imaging session will be scheduled on the same day as the mid-treatment FBCT.

Trial Locations (1)

B3H 2E2

Nova Scotia Health (QEII), Halifax

All Listed Sponsors
lead

Varian, a Siemens Healthineers Company

INDUSTRY